Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ke, Bin
NCT06506292: A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)	Recruiting	2	25	RoW	Adebrelimab, XELOX	Tianjin Medical University Cancer Institute and Hospital	Adebrelimab (SHR-1316), XELOX, GC/GEJC	08/26	08/27
NCT06033482: The Possible Range of No.12a Lymph Node Dissection of Locally Advanced Gastric Cancer	Recruiting	N/A	100	RoW	The reasonable range of No.12a lymph node dissection	Tianjin Medical University Cancer Institute and Hospital	Gastric Cancer, No.12a Lymph Node Dissection	07/24	12/24